Antibiotice S.A. (BVB:ATB)
2.160
-0.030 (-1.37%)
At close: Apr 3, 2025
Antibiotice Revenue
In the year 2024, Antibiotice had annual revenue of 686.57M RON with 11.58% growth. Antibiotice had revenue of 170.04M in the quarter ending December 31, 2024, with 20.28% growth.
Revenue
686.57M
Revenue Growth
+11.58%
P/S Ratio
2.05
Revenue / Employee
508.57K
Employees
1,350
Market Cap
1.41B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 686.57M | 71.28M | 11.58% |
Dec 31, 2023 | 615.29M | 110.29M | 21.84% |
Dec 31, 2022 | 505.00M | 126.17M | 33.31% |
Dec 31, 2021 | 378.83M | 31.60M | 9.10% |
Dec 31, 2020 | 347.22M | -47.92M | -12.13% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
S.P.E.E.H. Hidroelectrica | 9.83B |
OMV Petrom | 34.36B |
Banca Transilvania | 9.49B |
SNGN Romgaz | 7.93B |
BRD - Groupe Société Générale | 3.89B |
S.N. Nuclearelectrica | 5.93B |
Digi Communications | 11.60B |
S.N.T.G.N. Transgaz | 4.43B |